Free multistate pharmacy jurisprudence examination Practice Questions

Sample Practice Questions

Try these 10 sample questions from the multistate pharmacy jurisprudence examination practice bank. Each includes the answer and explanation. Continue with the interactive practice above to review the full question set.

1. 1For Maine's urgent-need insulin safety-net program, when does an eligible individual's insulin supply qualify as an urgent need?

   1. A. When the supply is expected to last less than 7 days
   2. B. When the supply is expected to last less than 14 days
   3. C. Only after the supply is completely exhausted
   4. D. Whenever fewer than 30 days remain

   Answer: A

   Explanation: Title 32 §13725 defines urgent need as “having readily available for use less than a 7-day supply of insulin” and needing insulin to avoid significant health consequences. The facts satisfy that threshold.

   Reference: Maine Pharmacy Act Current — 32 M.R.S. §13725(1)(G)

2. 2A PharmD student has submitted a Maine intern-license application but has not received the license. When may the student begin an APPE in Maine?

   1. A. Once the school confirms the APPE placement
   2. B. Once the preceptor signs the internship plan
   3. C. Once the Board receives the license application
   4. D. Once the Board actually issues the intern license

   Answer: D

   Explanation: "A student may not participate in either pharmacy practice experience until the board has actually issued a pharmacy intern license to the student." Submission, school confirmation, and preceptor approval do not replace issuance of the intern license.

   Reference: Maine Board of Pharmacy Rules, 02-392 C.M.R. chapters 1-38 — 02-392 C.M.R. ch. 6-A, student internship program, §3

3. 3An out-of-state wholesaler supplies prescription drugs to Maine pharmacies. What Maine licensure does the distribution require?

   1. A. A Maine Board manufacturer or wholesaler license
   2. B. Only the license held in the wholesaler's home state
   3. C. Only the receiving pharmacy's Maine retail license
   4. D. Only the wholesaler's federal DEA registration

   Answer: A

   Explanation: "All manufacturers and wholesalers whose products are distributed in the State in any manner must be licensed by the board." The rule applies to product distribution into Maine regardless of the wholesaler's location; the other credentials do not replace Maine Board licensure.

   Reference: Maine Pharmacy Act, 32 M.R.S. ch. 117 — 32 M.R.S. §13758(2)

4. 4Under Maine Board Rule Chapter 19, how long after its issue date may a controlled-substance prescription generally remain fillable?

   1. A. 30 days
   2. B. 60 days
   3. C. 90 days
   4. D. 15 months

   Answer: C

   Explanation: Chapter 19 provides, “No pharmacist may fill a prescription drug order for a controlled substance” more than 90 days after the prescription date.

   Reference: Maine Pharmacy Rules Ch 1 38 — 02-392 C.M.R. ch. 19, §2

5. 5A Maine pharmacy processes a written controlled-drug prescription in its automatic data-processing system. From which event does the two-year retention period begin?

   1. A. The date the practitioner issued the order
   2. B. The date the pharmacy first received the order
   3. C. The date the pharmacy first filled the order
   4. D. The date the pharmacy last filled the order

   Answer: D

   Explanation: "For orders processed by an automatic data processing system, the retention period begins on the date of last fill." This differs from the first-fill trigger for manually processed controlled orders.

   Reference: Maine Board of Pharmacy Rules, 02-392 C.M.R. chapters 1-38 — 02-392 C.M.R. ch. 24, §2(1)

6. 6A Maine pharmacist-license applicant intentionally leaves another state's disciplinary action off an application that requests it. Under Chapter 31, what is this act?

   1. A. Fraud or deceit in obtaining a license
   2. B. Unprofessional conduct in drug-product billing
   3. C. Noncompliance with continuing education rules
   4. D. A citation for a drug-outlet inspection violation

   Answer: A

   Explanation: "Intentionally withholding or misrepresenting any information requested on an application, including any information regarding criminal or disciplinary action taken by any state against an applicant;" Chapter 31 treats the intentional omission as fraud or deceit in obtaining licensure; the other categories concern billing, education, or outlet inspection.

   Reference: Maine Board of Pharmacy Rules, 02-392 C.M.R. chapters 1-38 — 02-392 C.M.R. ch. 31, §1(4)

7. 7A physician and pharmacist have just begun a Maine collaborative practice agreement. During the agreement's first three months, what drug-therapy activity may the pharmacist perform under it?

   1. A. Initiate drug therapy for covered patients
   2. B. Monitor drug therapy for covered patients
   3. C. Modify drug therapy for covered patients
   4. D. Discontinue drug therapy for covered patients

   Answer: B

   Explanation: "activity in the initial 3 months of a collaborative practice agreement be limited to monitoring drug therapy" Initiating, modifying, and discontinuing therapy may be added only after the required later review and scope determination.

   Reference: 02-392 C.M.R. ch. 39 — 02-392 C.M.R. ch. 39, §3(1)

8. 8A Maine pharmacist has a standing order to furnish a covered hormonal contraceptive but has not obtained Chapter 44 authorization. What is required before the pharmacist uses the expanded prescribing authority?

   1. A. A drug-administration certificate in place of authorization
   2. B. A signed collaborative agreement in place of authorization
   3. C. The standing order alone as complete authorization
   4. D. Board-issued contraceptive authorization before practice

   Answer: D

   Explanation: "No pharmacist shall prescribe, dispense and administer, including according to a standing order or a collaborative drug therapy management agreement, a self-administered hormonal contraceptive or an injectable hormonal contraceptive before having been issued authorization as described in this chapter by the board." The standing order does not bypass the Board authorization required for this expanded practice.

   Reference: 02-392 C.M.R. ch. 44 — 02-392 C.M.R. ch. 44, Authorization Required §1

9. 9Who shares responsibility with the prescriber for ensuring that a controlled-substance prescription was issued for a legitimate medical purpose?

   1. A. The wholesaler
   2. B. The pharmacist who fills the prescription
   3. C. The patient's insurer
   4. D. The pharmacy technician entering data

   Answer: B

   Explanation: Section 1306.04(a) states that “a corresponding responsibility rests with the pharmacist who fills the prescription.”

   Reference: Ecfr Part 1306 — 21 C.F.R. §1306.04(a)

10. 10A DEA-registered retail pharmacy wants to collect unwanted controlled substances from ultimate users. What authorization step must it complete to become a collector?

    1. A. Keep its current registration and file destruction records only
    2. B. Obtain a state wholesaler license instead of DEA authorization
    3. C. Modify its DEA registration to obtain collector authorization
    4. D. Appoint a reverse distributor without modifying registration

    Answer: C

    Explanation: "retail pharmacies that desire to be collectors shall modify their registration to obtain authorization to be a collector" Collector authorization is a DEA registration modification; existing pharmacy registration or disposal records alone do not authorize collection.

    Reference: 21 CFR Part 1317 — 21 C.F.R. §1317.40(a)